Physician profile
Larry Rodgers
NPI 1992891071
$355.68
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.49 · 2020: $77.32 · 2021: $57.02 · 2022: $61.26 · 2023: $35.47 · 2024: $67.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $87.24 | 2021-2024 | Pediarix, Bexsero, Rotarix |
| Merck Sharp & Dohme LLC | $73.55 | 2021-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Pfizer INC. | $59.66 | 2019-2024 | |
| Sobi, INC | $48.83 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $43.75 | 2020 | |
| Abbvie INC. | $16.04 | 2019 | |
| Shire North American Group INC | $15.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.